in IM DM medium without FBS for 1h. All cells were trypsinized and separated into three groups -suspension, adherent, and hydrogel in 500 µL of glucose free-DM EM .
For hydrogel experiments, control hydrogels were prepared without cells to quantify radionuclide trapping in hydrogels. For hydrogel synthesis, HA-NHS was dissolved in PBS containing Ca 2+ /M g 2+ without addition of glucose prior to mixing with serum and lysed blood.
To measure glucose uptake, 500 µL glucose free-DM EM containing 18 FDG (final concentration of 74 kBq/ml) was added to each sample and control well for 1h to measure glucose uptake.
Subsequently, cells/hydrogels were washed twice with cold PBS to remove any remaining free 18 FDG and lysed with proteinase K solution (10 mM Tris, 1 mM EDTA, 0.1% Trition X-100, and 0.1 mg/mL proteinase K). Counts were recorded in a gamma-counter (Perkin Elmer). After the gamma counting, radioactivity in the samples was allowed to decay by storing them in the -20°C freezer for 2 days. The hydrogels were manually crushed using a small piston (Sigma) and digested in proteinase K solution at 50°C for 24h. Double stranded DNA content was determined using the Quant-iT PicoGreen dsDNA Reagent and Kit (Invitrogen).
2-Photon Microscopy: M itochondrial membrane potential and α5 integrin-eGFP expression
were examined using an Olympus FV1000 M P microscope and 20X water immersion lens.
M itochondrial membrane potential (ΔΨm) was monitored by labeling cells with 100nM of tetramethylrhodamine methyl ester (TM RM) for 30 minutes [4] and excitation wavelength of 800 nm; α5 integrin-eGFP transduced cells were excited at 900 nm. Emitted light was collected by 3 photomultiplier tubes fitted with bandpass filters. 512x512 pixel images were collected at 37ºC
and image analysis was performed using Image J (NIH, http://rsb.info.nih.gov/ij/) as described previously [4] . For hydrogels, a series of 512x512 pixel images of 200 µm (Z-stack) were taken at multiple regions in the hydrogels with at least 20 slices in each stack. Signal quantification was performed by drawing a region of interest (ROI) and calculating mean fluorescence intensity which was normalized to fluorescent area.
Cell proliferation: Cell proliferation was monitored using the WST8 assay (Dojindo Laboratories). Cells were plated in 96 well plates (1000cells/well) and medium was changed every other day. Each condition had 6 wells per day, and one row was used to obtain a reading on a daily basis. M edium was changed after 24 hours of plating to DM EM (Catalog # 17-207-CV, Corning)
containing glutamine (2mM ) and FBS (10%); glucose (25mM ), pyruvate (25mM ) or (25mM) glucose+(1mM ) DM OG (Dimethyloxallyl Glycine) with and without oligomycin (4uM ) for 07 days. M edium was changed every other day. WST 8 reagent (10uL) was added 2h prior to reading the plate using SpectroM ax2 and 450 absorbance. Subsequent rows were scanned on a daily basis to plot a proliferation curve.
Western blot:
Western blots for AM PK, Akt, HIF-1α, FLAG and Cleaved Caspase Substrate M otif were performed as follows. Cells were washed twice using ice-cold PBS and lysed using RIPA buffer containing proteinase and phosphatase inhibitors. Cell lysates were clarified by centrifugation at >10 4 g for 10 min at 4°C. Protein estimation of cell lysate was done using the BCA assay (Pierce-Thermoscientific). Equal amounts of proteins were electrophoresed on precast Cell surface GLUT1 expression: HEK293 cells were used for transient transfection of FLAG-GLUT1 [5] constructs using Lipofectamine 2000 (Invitrogen). FLAG-GLUT1 is an exofacial construct which was used to detect surface levels of GLUT1. Cells were analyzed using FACscan (BD Biosciences, San Jose, CA) and FlowJo software (Tree Star, Inc., Ashland, OR). Cells were kept in suspension for 1h, 3h and 6h followed by washing with Ca ++ and M g ++ -free phosphate-buffered saline (PBS). Anti-Fc (BD Biosciences PharM ingen, San Diego, CA) was used for blocking. Subsequently, rabbit anti-FLAG (Sigma-Aldrich) was added followed by Alexafluor-588 donkey anti-rabbit (M olecular probes-Invitrogen) to determine FLAG surface expression. The relative intensity calculated reflected mean cell fluorescence of cell surface GLUT1 levels. To normalize for variable FLAG levels, the surface expression was normalized to the ratio of FLAG/Actin as described previously [5] .
Flow Cytometry for quantification of mitochondrial number:
We used M itoTracker Green FM (Cat#M 7514-ThermoFischer) which labels mitochondria regardless of mitochondrial membrane potential [6] . Cells were washed with PBS, harvested and incubated with 75nM
M itoTracker Green at 37°C for 30 min before washing them twice with PBS and analyzing the mean fluorescence intensity of the dye in cells, using FACscan (BD Biosciences, San Jose, CA), as previously described [6] . integrin-eGFP using Lipofectamine 2000. The plasmid was purchased from Addgene (Plasmid 15238) and has a Neomycin-resistance gene. Cells were selected for 5 days using 500µg/ml of G418 Neomycin to obtain >95% GFP positive cells prior to experiments. Imaging was performed using a 2-photon laser scanning fluorescence microscope.
Flow Cytometry for viability

PI3K-Akt Inhibition:
In order to evaluate the effect of Akt inhibition on cell metabolism and 99m Tc-pertechnectate uptake, 10µM -LY294002 (Sigma-L9908) a reversible PI3K inhibitor, 1µM-Wortmannin (Sigma-W1628) an irreversible PI3K inhibitor and 10µM -M K-2206 (Selleck Chemical) a reversible Akt inhibitor were used. Akt inhibition was confirmed by western blot for p-Akt. Prior to performing experiments using M K2206, effect of the drug on cell viability was assessed using 2 photon microscopy. CDCs were treated for 1 hr with M K-2206 (10µM );
subsequently, M K-2206 was washed by rinsing cells in PBS containing M g +2 /Ca +2 . Cells were then labeled with calcein and propidium iodide and imaged by 2-photon microscopy. Cell viability in hydrogels after M K-2206 pre-treatment was 93±4.29% at 24h, which was similar (p>0.45) to controls (~95%). Hydrogel preparation: Carboxyl groups in hyaluronic acid (HA, M W 16 kDa; LifeCore Biomedical) were modified to amine-reactive N-hydroxysuccinimide esters as previously described [3, 10] . Peripheral blood from Wistar Kyoto rats (Charles Rivers) was collected using heparinized and serum tubes. For serum isolation, blood was centrifuged at 1500 rpm for 10min.
RNA Isolation and RT-PCR:
In order to generate lysed blood, whole blood was frozen at -20 and subsequently thawed. All blood products were stored at -20°C until further use. Animals were euthanized according to the Johns Hopkins Animal Care and Use Guidelines.
HA:Bl:Ser hydrogels were prepared by mixing 1:1 of 10 w/v% HA-NHS dissolved in PBS containing 25mM glucose, with equal volume of lysed blood:serum (1:1) derived from rats. All polymerization was carried out at pH 7-7.4 and at room temperature for 3min. We chose a 1:1 (v/v) ratio for lysed blood and serum and HA in order to maximize high adhesivity of HA-NHS, growth factor concentration and adhesion motifs from blood products. In order to ensure functionality of the NHS groups, hydrogels were synthesized within 15-20 min of dissolving HA in glucose-containing PBS.
In vitro 99m
Tc-pertechnectate uptake [7, 8] : CDCs were transduced with a 3 rd generation lentivirus expres sing the human s odium-iodide symporter (Lv-CMV-hNIS) at an M OI of 20.
99m Tc-pertechnetate (11.1 kBq/mL) was added for 1h in cell/hydrogel culture media. Subs equently, cells/hydrogels were wash ed twice with cold PBS to remove any remaining free 99m Tcpertech netate. Cells/hy drogels were lysed with p roteinase K solution (10 mM Tris, 1 mM EDTA, 0.1% T rition X -100 , and 0.1 mg/mL proteinas e K). Cou nts were recorded using a gamma-counter (Perkin Elmer). After the gamma counting, radioactivity in the s amp les was allowed to decay by storing them in the -20°C freezer for 2 day s. The effect of perch lorate (100μM ), a s pecific N IS blocker on 99m Tc-pertechnetate uptake was measured by adding perchlorate to some wells prior to the addition of 99m Tc-pertechnetate. Total dsDNA was determined us ing Picogreen assay as des cribed [3] .
In vivo studies:
Animal surgery
Anesthesia was induced in male Wistar Kyoto rats (200-250 g, Charles River) with 5% isoflurane flowed in with 2 L/min oxygen, and maintained with 2% isoflurane. The heart was exposed through a left lateral thoracotomy in the 4 th and 5 th intercostal space. One million NIS + CDCs were encapsulated in hydrogels and applied epicardially. Subsequently, the chest was closed and the animals were allowed to recover prior to SPECT/CT imaging at 1 hour and 24 hours posttransplantation.
In vivo SPECT/CT imaging[3]
In order to determine the effect of cellular metabolism and Akt inhibition, X-ray computed tomography (CT) was performed on the microCT module with an X-ray tube voltage of 75 kVp. A total of 512 projections were acquired over a 360-degree range. The projections with 1,184 × 1,120 isotropic pixels (100 μm) were reconstructed into a CT volume of 512 3 isotropic voxels with 170 μm pixel size. The SPECT and CT were then registered using rigid body transform, with preset parameters specific to the system [3] .
SPECT image quantification [3] : For absolute quantification, a calibration factor (CF) was calculated from an experimental study by inserting a small hollow sphere filled with a known amount of radioactivity of 99m Tc or 201 Tl in water in an averaged rat-size water-filled cylindrical phantom to simulate a rat scan. Dose-response plot for 99m Tc-pertechnetate was obtained by dual isotope SPECT imaging of varying doses of 99m Tc-pertechnetate and 201 Tl and then used to calculate the calibration factor. SPECT data for phantom were acquired using exactly the same acquisition settings as those used in the animal experiments. In this case, CF (M Bq/i.i.) was defined as the quotient of the known activity concentration (M Bq/ml) within the radioactive sphere in the phantom divided by the measured mean image intensity (i.i/cm 3 ) within a ROI drawn over the small sphere in the SPECT image of the phantom.
To quantify tracer uptake in vivo, regions-of-interest (ROI) were manually defined in a region of increased focal tracer uptake and in a contralateral normal region of a mid-myocardial section. In the case of no observable increased focal myocardial tracer accumulation, an ROI was placed on the distal anterior wall. The total radioactivity in the region of interest was calculated by the image intensity within the ROI multiplied by the CF. The radioactivity concentration (M Bq/mL) within the ROI was calculated by the total activity divided by the volume of the ROI.
The background activity was calculated by placing an ROI in the basolateral wall of the heart. B: Normalization of total cellular FLAG-GLUT1 levels by western blot for FLAG, using beta-actin as the loading control. PI3K-Akt inhibition +/-oligo for 6h does not affect total cellular FLAG-GLUT1 protein expression indicating that reduced cell surface expression of FLAG-GLUT1 (Fig2E) was not due to reduction of total cellular protein levels. 
